Pregled bibliografske jedinice broj: 655537
Beta-blockers and diuretics usage in Croatia and Slovenia during a nine-year period
Beta-blockers and diuretics usage in Croatia and Slovenia during a nine-year period // Value Health 2011 ; 14(3): A49
Baltimore (MD), Sjedinjene Američke Države, 2011. str. 49-49 (poster, međunarodna recenzija, sažetak, ostalo)
CROSBI ID: 655537 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Beta-blockers and diuretics usage in Croatia and Slovenia during a nine-year period
Autori
Vitezić, Dinko ; Kučan, Marta ; Vitezić, Miomira ; Kovačević, Miljenko ; Mršić-Pelčić, Jasenka
Vrsta, podvrsta i kategorija rada
Sažeci sa skupova, sažetak, ostalo
Izvornik
Value Health 2011 ; 14(3): A49
/ - , 2011, 49-49
Skup
16th Annual International Congress of International Society for Pharmacoeconomics and Outcomes Research ISPOR
Mjesto i datum
Baltimore (MD), Sjedinjene Američke Države, 21.05.2011. - 25.05.2011
Vrsta sudjelovanja
Poster
Vrsta recenzije
Međunarodna recenzija
Ključne riječi
cardiovascular diseases; beta-blockers; diuretics; health-care costs
Sažetak
Cardiovascular diseases are the major health problem and adequate therapy, which includes usage of beta blockers (ATC, C07) and diuretics (ATC, C03), leads to reduction of cardiovascular morbidity and mortality. The aim of our study was to identify and analyze changes in the usage of these drugs in Croatia and Slovenia from 2000-2008 and to identify the rate of the generic drugs usage as well as the average price for 1 DDD. The data concerning consumption have been obtained from the International Medical Statistics database for Croatia and they are presented in defined daily doses per 1000 inhabitants per day (DDD/1000). Financial expenditure data are presented in Euros and the average cost per DDD was calculated for each drug group. The total usage of diuretics is on average 19% higher in Croatia and continually increasing in both countries. Consumption rate of furosemid among diuretics is lower in Slovenia (43.96% in 2008), while in Croatia 67.28% (2008). The generic drugs usage is higher in Croatia during the whole investigated period, e.g. in 2008, 87.4 % of all prescribed diuretics were generics in Croatia, and in Slovenia 59.4%. The average price per 1 DDD was more than twice lower in Croatia (0.08 EUR/DDD vs. 0.17 EUR/DDD in Slovenia). The beta blockers drugs usage is 13% higher in Slovenia, but generic drugs usage is higher in Croatia. Increased diuretics and beta blockers drug usage is comparable to worldwide trends, but drug prescribing patterns are different when comparing both countries. Although the generic drugs usage is relatively high in Croatia, it should be further supported and promoted. According to our investigation there is a possibility for further price reduction of diuretics and beta blockers in Slovenia. This is important as a tool to decrease costs of healthcare systems.
Izvorni jezik
Engleski
Znanstvena područja
Kliničke medicinske znanosti
POVEZANOST RADA
Projekti:
062-0620063-0060 - Uporaba kardiovaskularnih lijekova i značaj farmakoekonomskih procjena (Vitezić, Dinko, MZOS ) ( CroRIS)
Ustanove:
Medicinski fakultet, Rijeka
Profili:
Miljenko Kovačević
(autor)
Marta Kučan
(autor)
Jasenka Mršić-Pelčić
(autor)
Dinko Vitezić
(autor)
Citiraj ovu publikaciju:
Časopis indeksira:
- Current Contents Connect (CCC)
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- Social Science Citation Index (SSCI)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus
- MEDLINE